Artificial intelligence (AI) can match physician insulin dosing, maintaining target blood sugar levels in patients with type 2 diabetes. A study showed an AI-based insulin decision support system's ...
A 52-week, randomized, open-label, parallel-group, phase 3a trial with real-world elements was conducted at 176 sites in seven countries. A total of 1085 insulin-naive patients with type 2 diabetes ...
Glooko’s software already gives people with diabetes a single place to pool all of the data from their health-tracking devices, and, now, it’s taking a more active role in helping manage their ...
Hosted on MSN
Insulin Dos and Don’ts
If youre on insulin to treat type 1 or type 2 diabetes, its critical to know exactly how to use it. Insulin can be a very dangerous drug if used improperly, says Stanley Mathew, MD, an endocrinologist ...
The US Food and Drug Administration has cleared new decision-support software that aids in insulin dosing. In addition, Insulin Algorithms is "an affordable, easily adoptable tool for every-size ...
Following in the footsteps of Eli Lilly and Roche, Sanofi has quietly received FDA clearance for a smartphone app with a built-in insulin dose calculator. According to FDA documents, the app, cleared ...
ORLANDO -- Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve ...
Bigfoot Biomedical is doing its part to ensure that the possibility of building a smarter diabetes management system is more than just an urban legend. The tech maker has purchased a new algorithm ...
Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers.* Dexcom Smart Basal is FDA cleared and now the ...
ORLANDO -- For type 1 diabetes patients, switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) maintained glycemic control -- for those who used it as intended, the ...
Researchers tested the drug on 40 adults with long-term type 1 diabetes in the Insulin Resistance in Type 1 Diabetes Managed ...
Indianapolis-based pharma company Eli Lilly recently recieved FDA 510K clearance for a new mobile app called Go Dose, a diabetes management and insulin dosing app for users of Humalog, Lilly's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results